DENVER, Jan. 18, 2016 /PRNewswire/ -- Sage Analytics (www.sageanalytics.com), the developers of portable, laboratory-quality cannabis potency measurement systems, announced that Jason Lupoi, Ph.D., Director of Scientific Applications, will present at the Emerald Conference in Las Vegas, January 22, 2016.
Dr. Lupoi will speak about the challenges with current cannabis testing methodologies and what technologies can help provide solutions for the industry's evolving protocols.
"We are entering a critical period in the cannabis industry: Consumers are demanding more accurate potency measurements; Growers want to know each plant's individual characteristics – and not simply view the entire crop as a whole with a highly variable average; Labs are seeking new ways to provide higher throughput; Regulators are trying to fine-tune a system that has been widely reported as broken," Lupoi commented. "There are many pieces to the testing puzzle, and new ways to put the pieces together."
The Emerald Conference is the preeminent event devoted to the exploration and discussion of the Science of Cannabis, including Analytical Testing, R&D, Clinical Applications, Inter-Lab Comparisons, State Regulations, and Industry Standardization.
Industry experts will share their latest research and demonstrate new technologies, in an atmosphere of collaboration and partnership.
Dr. Lupoi graduated summa cum laude with a B.S. in Chemistry and earned a Ph.D. in Analytical Chemistry. As a Postdoctoral Fellow at the Joint BioEnergy Institute (a Lawrence Berkeley National Lab facility), he developed high-throughput analytical spectroscopy techniques. He has expertise in analytical methodologies and the challenges inherent with current cannabis testing technologies and protocols.
For more information on the Emerald Conference, visit: www.theemeraldconference.com.
For information on Sage Analytics, visit: www.sageanalytics.com, or call: 720-282-4550.
About Sage Analytics:
Sage Analytics created a shift in the cannabis industry by adopting FDA-approved technology used in the pharmaceutical industry, to test marijuana potency with a high degree of accuracy and affordability. Sage Analytics can replace or augment current testing methodologies, which are expensive and often insufficient due to the inherent drawbacks of small batch testing. Consumers, regulators and canna-business owners are demanding quicker and more accurate testing methods, and Sage Analytics provides a significant component to improving this industry-wide challenge.
SOURCE Sage Analytics